Myocarditis, an inflammation of the heart muscle, is a critical condition that students often encounter in their studies of cardiology. This comprehensive guide covers the etiology, diagnosis, and therapy of myocarditis, helping you understand its various forms, from viral infections to autoimmune responses, and how medical professionals approach this complex disease. Understanding myocarditis is crucial for anyone studying medicine or health sciences.

Understanding Myocarditis: Etiology, Diagnosis, and Therapy Summary

Myocarditis, or inflammation of the heart, most frequently results from infective agents, but can also stem from other inflammatory causes. It's important to distinguish true myocarditis from temporary cardiac depression caused by systemic inflammatory responses during severe conditions, which is often seen in intensive care units. Myocardial inflammation without obvious infection can be observed in conditions like sarcoidosis, giant cell myocarditis, eosinophilic myocarditis, or in association with autoimmune diseases such as polymyositis and systemic lupus erythematosus.

What is Fulminant Myocarditis?

Fulminant myocarditis is a severe, rapidly progressing form that can be caused by viral infection, checkpoint inhibitor therapy, giant cell myocarditis, or necrotizing eosinophilic myocarditis. It is often complicated by recurrent arrhythmias. Early recognition of fulminant myocarditis is vital because aggressive circulatory support can lead to recovery of near-normal cardiac function in more than half of patients. These patients are typically young adults who present with rapidly progressive cardiogenic shock after a severe febrile respiratory syndrome.

Etiology of Myocarditis: Causes and Mechanisms

Infections can damage the myocardium through direct invasion, disruption of cellular processes, production of cardiotoxic substances, or by stimulating chronic inflammation. Myocarditis has been linked to almost all types of infective agents, but is most commonly associated with viruses and the protozoan Trypanosoma cruzi.

Viral Myocarditis: Common Causes and Pathogenesis

The pathogenesis of viral myocarditis is often studied in animal models and typically involves three phases:

Direct Viral Invasion: Viruses, such as coxsackievirus, enter the body and infect organs with specific receptors, like those on the heart. Viral replication can directly injure and lyse myocardial cells. For example, enteroviral protease 2A degrades dystrophin, a key structural protein in myocytes.
Nonspecific Host Response: The body's innate immune system quickly responds to the infection, releasing cytokines and activating T- and B-cell populations. Early immunosuppression at this stage can worsen viral replication and cardiac damage.
Acquired Immune Response and Autoimmunity: The adaptive immune system targets viral proteins, involving T-cell infiltration and antibody production. If not properly regulated, this response can cause secondary damage to cardiac tissues, leading to ongoing inflammation and fibrosis. Some antibodies may even target host myocyte proteins.

Viruses rarely cause proven direct myocarditis in humans. Some commonly implicated viruses include:

Picornaviruses: Enteroviruses, coxsackievirus, echovirus.
Influenza: Frequently implicated during winter and spring.
DNA Viruses: Adenovirus, vaccinia, herpesviruses (varicella-zoster, cytomegalovirus, Epstein-Barr, HHV6).
Parvovirus B19 and HHV6: Often detected in patients with dilated cardiomyopathy (DCM) and even in healthy hearts, with their contribution to chronic cardiomyopathy being uncertain.
Human Immunodeficiency Virus (HIV): Historically linked to DCM, but incidence has decreased with highly active antiretroviral therapy (HAART). Cardiomyopathy in HIV can also be due to other coinfections or antiretroviral drugs.
Hepatitis C: Repeatedly implicated in cardiomyopathy, with potential improvement after interferon therapy. Hepatitis B rarely involves the heart unless associated with vasculitis.
Other Viruses: Mumps, respiratory syncytial virus, arboviruses (dengue, yellow fever), and arenaviruses (Lassa fever).
SARS-CoV-2: The systemic inflammatory response to COVID-19 can depress cardiac function. There is some evidence for direct cardiomyocyte invasion, and endothelial injury may contribute to myocardial ischemia.

Other Infectious Causes of Myocarditis

Beyond viruses, various other pathogens can cause myocarditis:

Parasitic Myocarditis:
Chagas' Disease: Caused by Trypanosoma cruzi, transmitted by the reduviid bug. It's the most common infective cause of cardiomyopathy worldwide. The parasite can directly damage myocytes and neurons, and chronic immune activation plays a role. It often leads to conduction system abnormalities, ventricular aneurysms, and heart failure.
African Trypanosomiasis: From the tsetse fly bite, with the East African form (T. brucei rhodesiense) rapidly progressing to myocarditis and heart failure.
Toxoplasmosis: Contracted from undercooked meat or feline feces, reactivates in immunocompromised hosts. Can cause myocarditis, pericardial effusion, and heart failure. Diagnosis involves IgM and IgG testing.
Trichinellosis: Caused by Trichinella spiralis larvae from undercooked meat. While larvae may invade the myocardium, heart failure is rare and attributed to the eosinophilic inflammatory response.
Echinococcus: Rarely causes cardiac involvement, but cysts can form and rupture.
Bacterial Infections:
Most bacterial infections rarely involve the heart directly, but severe systemic infections can depress contractility.
Diphtheria: Specifically affects the heart in nearly half of cases and is the most common cause of death. A toxin impairs protein synthesis, affecting the conduction system.
Clostridial Toxin: Causes myocardial damage, with gas bubbles and abscesses.
Streptococcal Infection: β-hemolytic streptococci are associated with acute rheumatic fever, leading to valve inflammation and fibrosis, but also myocarditis.
Other systemic bacterial infections include brucellosis, legionella, meningococcus, mycoplasma, psittacosis, and salmonellosis.
Tuberculosis: Can involve the myocardium directly or through pericarditis, but rarely with antibiotic treatment.
Whipple's Disease: Caused by Tropheryma whipplei, mainly affecting the GI tract, but can cause pericarditis, arteritis, valvular lesions, and heart failure.
Tick-Borne Infections:
Lyme Disease: Caused by Borrelia burgdorferi, often presenting with arthritis and conduction system disease. Rarely linked to chronic heart failure.
Other tick-borne illnesses include Rocky Mountain spotted fever, Q fever, and ehrlichiosis.

Non-Infective Myocarditis: Autoimmune and Inflammatory Causes

Myocardial inflammation can also occur without infection, often due to autoimmune responses or systemic inflammatory conditions. The understanding of cardiac transplant rejection has revealed the roles of antibodies, cytokines, and exposed myocardial antigens.

Granulomatous Myocarditis:
Sarcoidosis: A multisystem disease, often affecting lungs, but cardiac sarcoidosis can occur independently. It causes granulomas in the heart, leading to heart failure, arrhythmias, and conduction blocks. Diagnosis often requires biopsy of affected nodes and imaging (PET, MRI).
Giant Cell Myocarditis: Less common but more fulminant than sarcoidosis, often presenting with rapidly progressive heart failure and tachyarrhythmias. Characterized by diffuse granulomatous lesions and extensive inflammatory infiltrate, often with eosinophils. Associated with thymomas, thyroiditis, and other autoimmune diseases.
Checkpoint Inhibitor Myocarditis: A serious side effect of certain cancer immunotherapies (e.g., monoclonal antibodies against PD-1, CTLA4). These therapies unleash the immune response against cancer but can also attack host tissues, including myocytes. It presents as acute heart failure, arrhythmias, and skeletal myositis, with high mortality rates. Requires immediate high-dose glucocorticoid therapy.
Eosinophilic Myocarditis: Can be a manifestation of hypereosinophilic syndrome or seen with systemic eosinophilic syndromes (Churg-Strauss syndrome) or malignancies. Often presents with eosinophilic inflammatory response.
Hypersensitivity Myocarditis: An unexpected diagnosis, often attributed to medications like antibiotics, thiazides, or anticonvulsants. Biopsy shows lymphocytes, mononuclear cells, and a high proportion of eosinophils. Discontinuation of the trigger and high-dose glucocorticoids can be curative.
Systemic Inflammatory Diseases: Myocarditis is associated with polymyositis and dermatomyositis, which affect both skeletal and cardiac muscle. Connective tissue diseases like systemic lupus erythematosus more often cause pericarditis, vasculitis, or pulmonary hypertension.

Diagnosing Myocarditis: Key Clinical and Laboratory Approaches

The diagnosis of myocarditis involves a combination of clinical assessment, laboratory tests, and imaging. Due to the varied presentation, a systematic approach is essential for accurate identification.

Initial Evaluation Steps for Suspected Myocarditis

When myocarditis is suspected, the initial evaluation typically includes:

ECG: Electrocardiogram to detect changes suggestive of pericarditis, myocardial infarction, or arrhythmias.
Echocardiogram: To assess heart function, particularly ejection fraction, and wall motion abnormalities.
Serum Biomarkers: Measuring troponin and creatine phosphokinase (CPK) levels. Both cardiac and skeletal muscle fractions of CPK may be elevated.

Advanced Imaging and Biopsy in Myocarditis Diagnosis

Magnetic Resonance Imaging (MRI): Increasingly used for diagnosis, showing evidence of increased tissue edema and gadolinium enhancement, particularly in the mid-wall. Revised Lake Louise criteria for specificity now require both a T2-weighted criterion (edema) and a T1-based criterion (inflammatory injury).
Endomyocardial Biopsy: Indicated when new heart failure presents with conduction blocks or ventricular tachyarrhythmias, suggesting noninfectious inflammatory causes (e.g., sarcoidosis, giant cell myocarditis). While specific if positive, Dallas criteria (lymphocytic infiltrate with myocyte necrosis) are negative in 80–90% of clinical myocarditis cases due to sampling error, early resolution, or insensitivity to cytokine/antibody-mediated injury. Immunohistochemistry may identify lymphocyte subtypes but its specificity is uncertain.

Classifying Myocarditis: Possible, Probable, and Definite

Patients with recent or ongoing viral syndromes are classified into three levels of myocarditis diagnosis:

Possible Subclinical Acute Myocarditis: Typical viral syndrome without cardiac symptoms, but with elevated cardiac injury biomarkers, suggestive ECG, and/or reduced left ventricular ejection fraction or regional wall motion abnormality.
Probable Acute Myocarditis: Meets criteria for possible myocarditis and also presents with cardiac symptoms (shortness of breath, chest pain). When pericarditis symptoms are accompanied by elevated troponin/CK-MB or abnormal wall motion, perimyocarditis or myopericarditis may be used.
Definite Myocarditis: Diagnosed by histologic or immunohistologic evidence of inflammation on endomyocardial biopsy, regardless of other clinical or laboratory criteria.

Other Diagnostic Tools

Viral Titers: An increase in circulating viral titers between acute and convalescent blood samples supports acute viral myocarditis.
Respiratory Virus Panels: Can detect adenovirus, influenza, and coronavirus.
Anti-heart Antibodies: No established role; may be a result of injury rather than a cause.

Therapy for Myocarditis: Treatment Strategies

Currently, there is no specific therapy recommended for any stage of viral myocarditis. Treatment is primarily supportive and guided by general recommendations for dilated cardiomyopathy.

Therapy for Viral Myocarditis

Avoidance of Immunosuppression: During acute viral infection, anti-inflammatory or immunosuppressive medications are generally avoided as they can increase viral replication and myocardial injury in animal models.
Antiviral Agents: Specific antiviral agents (e.g., oseltamivir) have not been studied for cardiac involvement.
Ongoing Research: There's ongoing investigation into antiviral therapy for chronic viral persistence and immunosuppressive therapy for immune-mediated myocarditis (defined by immunohistologic criteria or antimyocardial antibodies without viral genomes). However, neither is currently recommended for routine use.
Supportive Care: Treatment follows guidelines for DCM, focusing on managing heart failure symptoms and maintaining fluid balance.

Therapy for Other Types of Myocarditis

Parasitic Myocarditis: Antiparasitic therapy is type- and stage-specific. For Chagas' disease, benzindazole and nifurtimox are used, but their efficacy in established cardiomyopathy is unclear. Toxoplasmosis uses combination therapy (e.g., pyrimethamine and sulfadiazine). Trichinellosis is treated with antihelminthic drugs and glucocorticoids.
Bacterial Myocarditis: Specific antibiotics should be administered as soon as possible, as seen in diphtheria. For other systemic bacterial infections, treatment is directed at the underlying infection.
Tick-Borne Myocarditis: Treated with doxycycline or other agents.
Non-Infective Myocarditis:
Sarcoidosis: High-dose glucocorticoids, often with methotrexate, are used to suppress inflammation, which may improve arrhythmias but less so impaired systolic function. Pacemakers and defibrillators may be indicated.
Giant Cell Myocarditis: Requires aggressive immunosuppression (glucocorticoids with other agents) or mechanical circulatory support/transplantation due to rapid progression.
Checkpoint Inhibitor Myocarditis: Immediate high-dose glucocorticoids are the initial therapy, potentially followed by other immunosuppressants.
Hypersensitivity Myocarditis: Discontinuation of the trigger agent and high-dose glucocorticoids are curative.

Myocarditis: Frequently Asked Questions for Students

What are the most common causes of myocarditis in young adults?

In young to middle-aged adults, myocarditis is often presumed to be viral, frequently presenting days to weeks after a viral syndrome with fever and myalgias. However, non-infectious causes like sarcoidosis, giant cell myocarditis, or even checkpoint inhibitor therapy are also recognized, especially in fulminant cases.

How is myocarditis diagnosed if a biopsy is often negative?

While endomyocardial biopsy is the definitive diagnostic tool when positive, its insensitivity means other criteria are crucial. Diagnosis relies on a combination of clinical presentation (symptoms of heart failure, chest pain, arrhythmias), elevated cardiac biomarkers (troponin, CPK), ECG changes, and advanced imaging like cardiac MRI (using Lake Louise criteria for edema and injury). Myocarditis is often classified as possible, probable, or definite based on these integrated findings.

Why are immunosuppressants avoided in acute viral myocarditis?

In acute viral myocarditis, immunosuppressive medications are generally avoided because animal models have shown their use can increase viral replication and worsen myocardial injury. The initial immune response is crucial for limiting viral infection. However, research is ongoing for immune-mediated myocarditis where a viral genome isn't detected.

Can myocarditis lead to long-term heart problems?

Yes, myocarditis can lead to long-term heart problems. While some patients, especially those with fulminant myocarditis who receive aggressive support, can recover near-normal ejection fraction, residual diastolic dysfunction may limit vigorous exercise. In other cases, ongoing inflammation or extensive fibrosis can lead to chronic dilated cardiomyopathy (DCM) or persistent arrhythmias, necessitating ongoing management and sometimes devices like pacemakers or defibrillators.

Myocarditis: Etiology, Diagnosis, and Therapy